top of page

Ketamine or Placebo in Patients With Major Depression and Advanced Cancer

About the study

NCT Trial Number

NCT04471818

The drug being studied

Ketamine

noun_Drug_2240951.png
noun_Institution_118530.png

Sponsored by

Instituto Nacional de Cancerologia de Mexico

noun_date_3237048.png

Trial Start Date

Nov-19

noun_capsule_138144.png

About the participants

Age seeking

18 Years to 65 Years

gender

All

noun_Mental Health_2683241.png

Primary condition of volunteers accepted

Depression

noun_square_138133.png

Accepts healthy volunteers?

No

To assess the efficacy of using ketamine treatment as a adjunct treatment for depression in patients who are diagnosed with advanced cancer.

Eyes Graffiti

Locations


Mexico
Instituto Nacional de Cancerología (INCan)
Mexico City, Mexico

Contact: Oscar Rodríguez Mayoral, MD
55 5628 0400
oscroma@gmail.com

​

​

​

​

Get in contact

Find a study site convenient for you below, then email yourself the contact details and next steps

bottom of page